{"id":2369,"date":"2021-01-21T14:11:19","date_gmt":"2021-01-21T13:11:19","guid":{"rendered":"https:\/\/bluebirds.partners\/pmo-de-plusieurs-programmes-de-transformation-pour-un-acteur-de-lindustrie-pharmaceutique\/"},"modified":"2021-04-20T20:26:14","modified_gmt":"2021-04-20T18:26:14","slug":"pmo-de-plusieurs-programmes-de-transformation-pour-un-acteur-de-lindustrie-pharmaceutique","status":"publish","type":"post","link":"https:\/\/bluebirds.partners\/en\/pmo-de-plusieurs-programmes-de-transformation-pour-un-acteur-de-lindustrie-pharmaceutique\/","title":{"rendered":"PMO of several transformation programmes for a pharmaceutical organisation"},"content":{"rendered":"\n<h3 class=\"wp-block-heading\">Context &amp; Objectives<\/h3>\n\n\n\n<p>Our client is a major player in the pharmaceutical industry.<br>Our client created the PMO (Project Management Office) role at Group level to support the implementation of a portfolio of 20 transformation programmes on several subjects: information systems, digital transformation, industrial performance, compliance and traceability, integrating an acquisition in the USA, well-being at work, etc.<\/p>\n\n\n\n<p>The client engaged a consultant from the community to help them speed up the implementation of transformation programmes.<\/p>\n\n\n\n<h3 class=\"wp-block-heading\">Procedural approach<\/h3>\n\n\n\n<ul class=\"wp-block-list\"><li>Risk analysis of the 20 portfolio programmes<\/li><li>Identification of good practices and generalisation for the various programmes<\/li><li>Modelling of priorities between programmes to prioritise them, based on economic and user impacts<\/li><\/ul>\n\n\n\n<h3 class=\"wp-block-heading\">Results<\/h3>\n\n\n\n<ul class=\"wp-block-list\"><li>Definition of Group rules for the strategic and operational framing of programmes<\/li><li>Definition and implementation of the Governance of programmes and reporting bodies to the Executive Committee<\/li><\/ul>\n","protected":false},"excerpt":{"rendered":"<p>Context &amp; Objectives Our client is a major player in the pharmaceutical industry.Our client created the PMO (Project Management Office) role at Group level to support the implementation of a [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":2167,"comment_status":"closed","ping_status":"open","sticky":false,"template":"page-case-study.php","format":[59],"meta":{"_acf_changed":false,"footnotes":""},"categories":[60],"tags":[],"class_list":["post-2369","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-pharma-sante-chimie-en","format-case-studies-en"],"acf":[],"_links":{"self":[{"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/posts\/2369","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/comments?post=2369"}],"version-history":[{"count":6,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/posts\/2369\/revisions"}],"predecessor-version":[{"id":2774,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/posts\/2369\/revisions\/2774"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/media\/2167"}],"wp:attachment":[{"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/media?parent=2369"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/categories?post=2369"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/tags?post=2369"},{"taxonomy":"format","embeddable":true,"href":"https:\/\/bluebirds.partners\/en\/wp-json\/wp\/v2\/format?post=2369"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}